In Jun Yang

Seoul National University Bundang Hospital

Papers

1

Total Citations

12

H-Index

1

About

Dr. In Jun Yang is a leading surgical oncologist whose research focuses on the molecular biology of colorectal cancer and the advancement of minimally invasive hepatobiliary surgery. His seminal work on *KRAS* mutations has reshaped clinical prognostication, demonstrating that codon 12 mutations carry significant prognostic value while codon 13 mutations do not—a distinction that directly informs treatment stratification. This highly cited paper (12 citations) underscores his ability to translate genomic nuances into actionable clinical insights. Beyond molecular oncology, Dr. Yang has been instrumental in refining robotic liver resection (RLR) techniques, contributing to a new international consensus that clarifies the benefits and ongoing controversies of robotic systems in complex hepatic surgery. His work bridges the gap between precision oncology and surgical innovation, offering patients safer, more effective interventions. With a growing citation footprint, Dr. Yang’s research continues to influence both surgical practice and cancer biology, making him a pivotal figure in the evolution of personalized, technology-driven cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
12
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Different oncological features of colorectal cancer codon-specific <i>KRAS</i> mutations: Not codon 13 but codon 12 have prognostic value
12 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Seoul National University Bundang Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago